Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.
about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursHow Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?Management of patients with hepatic metastases from neuroendocrine tumorsInterventional therapies of unresectable liver metastases.Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.Acute thrombocytopenia: An uncommon complication occurring following transarterial chemoembolization in a patient with neuroendocrine hepatic metastasesImaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Therapy for metastatic pancreatic neuroendocrine tumors.Multimodal management of neuroendocrine liver metastases.Evaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumorsRole of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.MRI-guided laser ablation of neuroendocrine tumor hepatic metastasesTreatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.A multimodal approach to the management of neuroendocrine tumour liver metastasesPharmacotherapy of Zollinger-Ellison syndrome.The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursMolecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasTherapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesRefractory carcinoid syndrome: a review of treatment options.Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging.Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?Liver-specific therapies for metastases of neuroendocrine pancreatic tumorsSurgical treatment of gastrointestinal neuroendocrine tumors.Surgical treatment of liver metastases in neuroendocrine neoplasms.Amyloidosis and spontaneous hepatic bleeding, transcatheter therapy for hepatic parenchymal bleeding with massive intraperitoneal hemorrhage: a case report and review of the literature.Zollinger-Ellison syndrome: recent advances and controversies.Therapeutic strategies for neuroendocrine liver metastases.Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies.Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver.Radiotherapy for urinary bladder pheochromocytoma with invasion of the prostate: A case report and literature review.Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver MetastasesRecent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors.Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes.Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma.
P2860
Q24603675-6DCABE4B-B488-4F8E-8FED-D7FF31EB98ADQ26751659-4FEF6AB9-B2E5-4E5A-B37B-46EAE2688590Q26764993-1FA53623-8FCC-43C9-8E4C-C28A2FB1902BQ27008832-A01767A8-CD98-45B1-8915-0CE3D679F5A2Q31030760-BA48AFBB-8B69-4395-88F9-494F49F2791EQ33401986-01F676BE-03FF-4E09-A609-6BF20ECDCD61Q33424372-10E2E3F5-F1D8-440F-A6A1-8915E5C67660Q33658301-E533009B-D213-494B-BBAA-4B3F4669CE73Q34130243-DE03E211-8D30-4506-9EE1-5C547EDDD7C3Q34248487-6A5AB2BC-144F-477F-A579-540E36642DB9Q34301030-176C062D-98C1-4160-89B4-04606FEBBA2AQ34357869-0B5E5EE2-3053-470B-BEBB-F93E3C3D9E7BQ34528199-C4CED432-90E2-4436-A09C-FFE79EB81B9FQ34688938-A06C8FBB-F752-49E4-91D8-F7079BA0CB0FQ34702065-9E6A90B8-C815-44CB-8A9F-6A28E50EA6A8Q35159199-491A68C9-425C-40FC-9105-6C544977712AQ35371197-05180232-7682-4FF4-A680-E942042AF24EQ35810562-EC2B8097-DE74-4786-9DA6-3489E28DC7CDQ36632665-4DDE7033-678A-4BB4-A5D1-79753912F037Q36755905-97FD386E-D0C3-4AFF-8546-CA390C226605Q36804496-03807536-D243-45F4-98CB-60C83B5C3C8BQ37125550-6386C47E-F4DE-4832-BD70-3F63F17D4291Q37632161-02567142-332E-4CBD-9351-C6E198411758Q37673407-70843235-E4AC-4BB1-AC97-94D7C9DB1EFCQ37808643-9736B849-D73B-4148-875F-B0E5D5AFBCE6Q37821300-B3246C6E-B699-469F-ADC4-0942725BAD4FQ37833560-9562122B-A0CA-4318-8FBA-31330A064DEAQ37982721-3E420E86-BB5C-4CCC-B9B7-1A3A90237013Q38127633-4035B396-352E-48AF-BC14-1C749126C710Q38150165-7A03E90F-63C6-4EE1-807C-77E7A759FE35Q38255979-FDA6D0D7-126D-40BD-AAD7-F04A61ABBE5EQ38262113-3D9F0D06-F3FB-4BDC-88EE-3DBF7B4FC74FQ38319152-F966ED22-13D8-491B-9C82-42C523CEB797Q38547878-ADC2C80E-CB40-4FE2-B325-B076EDCDD9F9Q38868048-8DBED63D-E946-454C-BD64-A2463D048163Q39156920-08203863-A2CE-41D7-9F16-D92B04F491A8Q39773838-7E09B02B-9763-4399-9925-94F0923C2307Q40869761-A3B23A2D-7620-48DE-9B9F-C42EE26AF61EQ41196104-E4889EA4-EECA-423F-ACF3-B475DF40357CQ41390489-98077C12-5B09-4359-95E7-A1926301ACCB
P2860
Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liver metastases of neuroendoc ...... lization and thermal ablation.
@en
Liver metastases of neuroendoc ...... lization and thermal ablation.
@nl
type
label
Liver metastases of neuroendoc ...... lization and thermal ablation.
@en
Liver metastases of neuroendoc ...... lization and thermal ablation.
@nl
prefLabel
Liver metastases of neuroendoc ...... lization and thermal ablation.
@en
Liver metastases of neuroendoc ...... lization and thermal ablation.
@nl
P2093
P1476
Liver metastases of neuroendoc ...... olization and thermal ablation
@en
P2093
Alborz Hedayati
Katrin Eichler
Stefan Zangos
Thomas J Vogl
P304
P356
10.1016/J.EJRAD.2008.08.008
P577
2008-10-01T00:00:00Z